Mostrando entradas con la etiqueta Madre. Mostrar todas las entradas
Mostrando entradas con la etiqueta Madre. Mostrar todas las entradas

viernes, 24 de agosto de 2012

Most Mutations Come from Dad: New Insights Into Age, Height and Sex Reshape Views of Human Evolution

ORIGINAL: Science Daily

Humans inherit more than three times as many mutations from their fathers as from their mothers, and mutation rates increase with the father's age but not the mother's, researchers have found in the largest study of human genetic mutations to date. (Credit: © yanlev / Fotolia)
ScienceDaily (Aug. 23, 2012) — Humans inherit more than three times as many mutations from their fathers as from their mothers, and mutation rates increase with the father's age but not the mother's, researchers have found in the largest study of human genetic mutations to date.

The study, based on the DNA of around 85,000 Icelanders, also calculates the rate of human mutation at high resolution, providing estimates of when human ancestors diverged from nonhuman primates. It is one of two papers published this week by the journal Nature Genetics as well as one published at Nature that shed dramatic new light on human evolution.

"Most mutations come from dad," said David Reich, professor of genetics at Harvard Medical School and a co-leader of the study. In addition to finding 3.3 paternal germ line mutations for each maternal mutation, the study also found that the mutation rate in fathers doubles from age 20 to 58 but that there is no association with age in mothers -- a finding that may shed light on conditions, such as autism, that correlate with the father's age.

The study's first author is James Sun, a graduate student in Reich's lab who worked with researchers from deCODE Genetics, a biopharma company based in Reykjavik, Iceland, to analyze about 2,500 short sequences of DNA taken from 85,289 Icelanders in 24,832 father-mother-child trios. The sequences, called microsatellites, vary in the number of times that they repeat, and are known to mutate at a higher rate than average places in the genome.

Reich's team identified 2,058 mutational changes, yielding a rate of mutation that suggests human and chimpanzee ancestral populations diverged between 3.7 million and 6.6 million years ago.

A second team, also based at deCODE Genetics (but not involving HMS researchers), published a paper this week in Nature on a large-scale direct estimate of the rate of single nucleotide substitutions in human genomes (a different type of mutation process), and came to largely consistent findings.

The finding complicates theories drawn from the fossil evidence. The upper bound, 6.6 million years, is less than the published date of Sahelanthropus tchadensis, a fossil that has been interpreted to be a human ancestor since the separation of chimpanzees, but is dated to around 7 million years old. The new study suggests that this fossil may be incorrectly interpreted.

Great Heights

A second study led by HMS researchers, also published in Nature Genetics this week, adds to the picture of human evolution, describing a newly observable form of recent genetic adaptation.

The team led by Joel Hirschhorn, Concordia Professor of Pediatrics and professor of genetics at Boston Children's Hospital and HMS, first asked why closely-related populations can have noticeably different average heights. David Reich also contributed to this study.

They examined genome-wide association data and found that average differences in height across Europe are partly due to genetic factors. They then showed that these genetic differences are the result of an evolutionary process that acts on variation in many genes at once. This type of evolution had been proposed to exist but had not previously been detected in humans.

Although recent human evolution is difficult to observe directly, some of its impact can be inferred by studying the human genome. In recent years, genetic studies have uncovered many examples where recent evolution has left a distinctive signature on the human genome. The clearest "footprints" of evolution have been seen in regions of DNA surrounding mutations that occurred fairly recently (typically in the last several thousand years) and confer an advantageous trait, such as resistance to malaria. Hirschhorn's team observed, for the first time in humans, a different signature of recent evolution: widespread small but consistent changes at many different places in the genome, all affecting the same trait, adult height.

"This paper offers the first proof and clear example of a new kind of human evolution for a specific trait," said Hirschhorn, who is also a senior associate member of the Broad Institute. "We provide a demonstration of how humans have been able to adapt rapidly without needing to wait for new mutations to happen, by drawing instead on the existing genetic diversity within the human population."

Average heights can differ between populations, even populations that are genetically very similar, which suggests that human height might have been evolving differently across these populations. Hirschhorn's team studied variants in the genome that are known to have small but consistent effects on height: people inheriting the "tall" version of these variants are known to be slightly taller on average than people inheriting the "short" versions of the same variants.

The researchers discovered that, in northern Europe, the "tall" versions of these variants are consistently a little more common than they are in southern Europe. The combined effects of the "tall" versions being more common can partly explain why northern Europeans are on average taller than southern Europeans. The researchers then showed that these slight differences have arisen as a result of evolution acting at many variants, and acting differently in northern than in southern Europe.

"This paper explains -- at least in part -- why some European populations, such as people from Sweden, are taller on average than others, such as people from Italy," Hirschhorn said.

The researchers were only able to detect this signature of evolution by using the results of recent genome-wide association studies by the GIANT consortium, which identified hundreds of different genetic variants that influence height.

viernes, 1 de junio de 2012

Discovery Uses 'Fracture Putty' to Repair Broken Bone in Days

ORIGINAL: ScienceDaily

ScienceDaily (Feb. 7, 2012) — Broken bones in humans and animals are painful and often take months to heal. Studies conducted in part by University of Georgia Regenerative Bioscience Center researchers show promise to significantly shorten the healing time and revolutionize the course of fracture treatment.

A team of University of Georgia researchers created a new "fracture putty" to speed healing of bone fractures. From left to right are Steve Stice, Jennifer Mumaw, Erin Jordan and John Peroni. (Credit: Image courtesy of University of Georgia)
"Complex fractures are a major cause of amputation of limbs for U.S. military men and women," said Steve Stice, a Georgia Research Alliance Eminent Scholar, animal and dairy scientist in the UGA College of Agricultural and Environmental Sciences and director of the UGA Regenerative Bioscience Center.

"For many young soldiers, their mental health becomes a real issue when they are confined to a bed for three to six months after an injury," he said. "This discovery may allow them to be up and moving as fast as days afterward."

Stice is working with Dr. John Peroni to develop a fast bone healing process. "This process addresses both human and veterinary orthopedic needs," said Peroni, an associate professor of large animal surgery in the UGA College of Veterinary Medicine and a member of the RBC.

Peroni and Stice are leading a large animal research project funded by the U.S. Department of Defense. The project includes scientists and surgeons from the Baylor University College of Medicine, Rice University and the University of Texas, who conducted the early studies.

Engineering new bone

"Healing of critical-size defects is a major challenge to the orthopedic research community," Peroni said. "Large-bone defects must be stabilized and necessitate technologies that induce rapid bone formation in order to replace the missing tissue and allow the individual to return to rapid function. To date, no single material can suffice."

The group they lead is a multidiscipline and multi-institutional group actively working on bone tissue engineering.

"Our group has been working productively together on numerous projects through the last several years," Stice said, "So, a collegial relationship and successful collaborative working relationship is already established."

Between 2009 and 2011, the collaborations received a $1.4 million grant from the DOD for the use of stem cells in fracture healing to be tested in sheep.

"In our experiences with large animal models, following the guidelines established by our animal care and use committee," Stice said, "we have been successful in formulating a product that contains mesenchymal stem cells and allows them to survive in the environment of the fracture long enough to elicit the rapid formation of new bone."

This year, the group showed bone can be generated in sheep in less than four weeks. The speed in which bone is formed is one of the truly unique features of this study.

Fracture putty

To start the bone regeneration process, the RBC used adult stem cells that produce a protein involved in bone healing and generation. They then incorporated them into a gel, combining the healing properties into something Stice calls "fracture putty."

With Peroni's assistance, the Houston-based team used a stabilizing device and inserted putty into fractures in rats. Video of the healed animals at two weeks shows the rats running around and standing on their hind legs with no evidence of injury. The RBC researchers are testing the material in pigs and sheep, too.

"The small-animal work has progressed, and we are making good progress in large animals," he said.

More work is needed to get to human medical trials, but the threat of losing federal funding for biomedical work through the DOD means they will have to find new ways to fund the project.

Next steps

"The next step is to show that we can rapidly and consistently heal fractures in a large animal," Peroni said, "then to convert it to clinical cases in the UGA [College of Veterinary Medicine] clinics where clinicians treat animals with complex fractures all the time."

Once they have something that works for animals, it will be passed over to the DOD for human use.

Peroni, who is chairman of the North American Veterinary Regenerative Medicine Association, is hopeful this material will be promoted to the veterinary and human medical fields through the educational efforts of NAVRMA and the RBC.

However, the RBC isn't the only group working on a faster fix for broken bones.

"Our approach is biological with the putty," Stice said. "Other groups are looking at polymers and engineering approaches like implants and replacements which may eventually be combined with our approach. We are looking at other applications, too, using this gel, or putty, to improve spinal fusion outcomes."

One of the best hopes for the fracture putty is in possible facial cranial replacements, an injury often seen on the battlefield.



The project ends in mid-2012. "By then we are to deliver the system to the DOD," Stice said.

jueves, 19 de abril de 2012

Pionero en células madre e ingeniero en código abierto son galardonados con el "Premio Millennium de Tecnología 2012"

ORIGINAL: TechnologyAcademyFinnland
19 de abril 2012



La Academia de Tecnología de Finlandia ha declarado hoy que dos destacados innovadores, Linus Torvalds y el Dr. Shinya Yamanaka, ganadores del importante premio a la innovación tecnológica Premio Millenium de Tecnología de 2012, . Los galardonados, siguen los pasos de los vencedores anteriores, como el creador de la World Wide Web, Sir Tim Berners-Lee, en una ceremonia que se celebrará en Helsinki, Finlandia, el miércoles 13 de junio de 2012, cuando el ganador del Gran Premio será anunciado. La bolsa de premios es superior a 1 millón de euros.

Linus Torvalds, Finlandia / EE.UU.
Linus Torvalds. ZDnet
En reconocimiento a su creación de un nuevo sistema operativo de código abierto utilizado en computadores que llevan a que el núcleo de Linux. La libre disponibilidad de Linux en la Web rápidamente causó una reacción en cadena que conduce a un cuyo gran desarrollo y puesta a punto equivalen a 73.000 años-hombre. Hoy, millones de computadoras, teléfonos inteligentes y las grabadoras de video digital como TiVo  se ejecutan en Linux. El logro de Linus Torvalds logros han tenido un gran impacto en el desarrollo de software compartido, trabajo en red y la apertura de la web, haciéndola accesible a millones, si no miles de millones.

El Dr. Shinya Yamanaka, Japón
Dr. Shinya Yamanaka. Wikipedia
En reconocimiento a su descubrimiento de un nuevo método para desarrollar células madre pluripotentes inducidas para la investigación médica que no se basan en el uso de células madre embrionarias. Usando su método para crear células madre, los científicos de todo el mundo están haciendo grandes avances en la investigación en las pruebas de drogas y la biotecnología médica que deberían conducir, algún día a el crecimiento exitoso de los tejidos de implantes para la cirugía clínica y la lucha contra enfermedades incurables como el cáncer, la diabetes y de Alzheimer. El Dr. Yamanaka está específicamente nombrado por su destacado trabajo en la metodología éticamente sostenible.


Premio Millennium de Tecnología
El Premio Millennium de Tecnología es un homenaje de Finlandia a la vida, la mejora de la innovación tecnológica. El premio se concede cada dos años por una innovación tecnológica que mejora significativamente la calidad de vida humana, actual y en el futuro. Es otorgado por la Technology Academy Finland, una fundación independiente constituida por la industria finlandesa en asociación con el Estado finlandés. Los galardonados fueron seleccionados por el Patronato de la Fundación sobre la base de las recomendaciones formuladas por el Comité de Selección Internacional.

Linus Torvalds
El Dr. Shinya Yamanaka

Comité de Selección Internacional tiene amplia experiencia tecnológica
Las candidaturas elegibles han sido examinados por el Comité de Selección Internacional, una red distinguido de los principales científicos finlandeses e internacionales y tecnólogos. La decisión final sobre todos los laureados se realiza por el Consejo de la Technology Academy Finland sobre la base de una propuesta de la CAI. El ganador del Gran Premio serán anunciados en una ceremonia festiva en Helsinki el 13 de junio de 2012.

Linus Torvalds dijo:

"El software es muy importante en el mundo moderno para no ser desarrollado a través de fuentes abiertas. El impacto real de Linux es semejante a una forma de permitir a las personas y empresas construir en la parte superior del mismo para hacer su propia cosa. Finalmente estamos llegando al punto en que "los datos son sólo de datos", y no tenemos todos estos canales especiales absurdos de comunicación para las diferentes formas de datos ".

El Dr. Yamanaka dijo:

"En el siglo 21, la biología médica avanza a un ritmo más rápido que antes y la medicina personalizada estará fácilmente disponible en un futuro no lejano. Las iPS derivadas de células células diferenciadas podría tratar la anemia de células falciformes y lesiones de la médula espinal. Ya hay planes para llevar a cabo un ensayo clínico en algunos pacientes con enfermedad macular relacionada con la edad en los próximos años."

"Mis objetivos en la década incluyen el desarrollo de nuevos fármacos para enfermedades intratables mediante el uso de tecnología de células iPS y llevar a cabo ensayos clínicos psra usarlos en algunos pacientes con enfermedad de Parkinson, diabetes o enfermedades de la sangre."

El Dr. Ainomaija Haarla, el presidente de la Academia de Tecnología de Finlandia, dijo:

"Hemos tenido muchas nominaciones dignas sobre las cuales deliberar, pero al final las hemos reducido a estos dos candidatos que han hecho un impacto tan significativo en el campo de la informática y la investigación con células madre. Espero que este anuncio conduzca a un mayor reconocimiento para estos científicos extraordinarios y las tecnologías que han desarrollado. De estos dos hombres además se hablará durante los siglos por venir. "

Notas para los editores:
1. Para preguntas de los medios internacionales, por favor póngase en contacto con:
Rob Blackhurst Apollo Relaciones Públicas rob@apollopublicrelations.com 00 44 787 9423 341

2. Para preguntas de los medios finlandeses, por favor póngase en contacto con:
Niina Suhonen, Jefe de Comunicaciones y Marketing, Technology Academy Finland
nombre.apellido (a) technologyacademy.fi, tel. +358 40 8439 438

3. Contactos en la Academia de Tecnología de Finlandia
El Dr. Tech. Ainomaija Haarla, Presidente y CEO
nombre.apellido (a) technologyacademy.fi, tel: +358 40 716 0703
Canciller Jarl-Thure Eriksson, Abo Akademi University, Presidente del Comité Internacional de Selección, nombre.apellido (a) abo.fi, tel. +358 40 5012 570

Más información sobre el Premio y los miembros del Comité Internacional de Selección en: www.millenniumprize.fi

Información adicional acerca de Technology Academy Finland en:
www.technologyacademy.fi

Más información sobre los premiados y sus innovaciones:
Historias de caso, entrevistas, fotografías y vídeos sobre los premiados se encuentran disponibles en www.millenniumprize.fi

Academia de Tecnología de Finlandia (TAF) es una fundación independiente con la misión de apoyar la investigación científica y las nuevas tecnologías que beneficien a la humanidad y mejorar la calidad de vida de las personas. TAF otorga el bienal Premio del Milenio Tecnología y ejecuta eventos asociados, tales como el Campamento Anual de la Juventud del Milenio. También promueve la TAF Finlandia como un país de alta tecnología, participando activamente en las redes mundiales en la comunidad científica, las empresas y las organizaciones no gubernamentales.

Entre los ganadores anteriores
El Premio Millennium de Tecnología se ha adjudicado en cuatro ocasiones. El Premio inaugural fue otorgado en 2004 a Sir Tim Berners-Lee, inventor de la World Wide Web. En 2006, el Premio se otorgó al profesor Shuji Nakamura, inventor del revolucionario nuevas fuentes de luz - de color azul brillante, verde y blanco LED y un láser azul. En 2008, el profesor Robert Langer ganó el premio por su trabajo innovador en la liberación controlada de fármacos y para el desarrollo de biomateriales innovadores para su uso en la regeneración de tejidos. El cuarto premio fue otorgado al profesor Michael Grätzel en 2010 por sus desarrollos innovadores en tinte de células solares sensibilizadas. La nueva tecnología tendrá un impacto significativo en el desarrollo de soluciones energéticas del futuro, y las células de Grätzel se espera que desempeñen un papel importante y extensa en aplicaciones de energía renovable.

Lo que el comité de selección de dicho acerca de laureados de este año

Linus Torvalds
"En reconocimiento de la creación libre de prejuicios de un nuevo sistema operativo de código abierto que lleva a gran parte del núcleo de Linux explotación. La disponibilidad gratuita en la Web rápidamente causó una reacción en cadena que conduce a un mayor desarrollo y puesta a punto vale la pena el equivalente de 73.000 años-hombre. Hoy en día el número estimado de usuarios es de 30 millones de dólares. El logro de Linus Torvalds ha tenido un gran impacto en el desarrollo de software y en cuestiones culturales y éticas de la red y la apertura de la web. "

El Dr. Shinya Yamanka
"En reconocimiento del descubrimiento de un nuevo método y el desarrollo de los procedimientos técnicos necesarios para producir células madre pluripotentes inducidas a partir de tejido celular normal. El logro tiene un gran impacto en la investigación en la medicina y la biotecnología, las células madre pluripotentes ya se utilizan para las pruebas de drogas médicas y el crecimiento de los tejidos de implantes. El descubrimiento del Dr. Yamanaka también tiene una influencia ética fundamental, ya que elimina la necesidad de que las células madre embrionarias. Él es, sin duda, identificado como el padre de la innovación ".

Socios del Premio de Tecnología del Milenio
Kemira, Neste Oil, Nokia, Outotec, SEB,
Cargotec, la FIM, Fortum, Gasum, Halton, Lönnberg, Metso, Metsägroup, Ruukki, Vaisala, Wärtsilä